logo Research, Innovation and Dissemination Centers

Obesity and Comorbidities Research Center

CEPID 2013-2024

Website: www.ocrc.org.br
 
Principal investigator: Licio Augusto Velloso 
Education and knowledge diffusion coordinator: Ronaldo Aloise Pilli 
Technology transfer coordinator: João Eduardo de Morais Pinto Furtado

HOST INSTITUTION
University of Campinas (UNICAMP)
Rua Carl Von Linnaeus, s/n, Bloco Z - IB/Unicamp
Cidade Universitária Zeferino Vaz - Barão Geraldo
13083-864 - Campinas, SP 

ASSOCIATED INSTITUTIONS
University of São Paulo (USP)
São Paulo State University (UNESP) 
Federal University of São Paulo (UNIFESP)

BV-FAPESP: research projects supported in this Center 

OCRC in the Media: news about the Center

 

The Obesity and Comorbidities Research Center (OCRC) is one of the Research, Innovation and Dissemination Centers (RIDC) supported by FAPESP, and is active since June 2013.

OCRC coordinates scientific efforts to find solutions for obesity, a disease highly associated with a number of serious health problems such as type 2 diabetes, hypertension, atherosclerosis, and certain kinds of cancer. The overall mortality directly and indirectly associated with obesity is rapidly increasing in Brazil and all around the world – so much so that, today, it is considered a global epidemic.

The OCRC staff is constantly in contact with the industry and other potential users of the knowledge and products obtained through our research in order to speed up the transfer of knowledge to society.

 

RESULTS OF RESEARCH CONDUCTED AT THE CENTER:
Researchers will study body fat immune cells to understand obesity-associated inflammation
Researchers will study body fat immune cells to understand obesity-associated inflammation

2020-06-24

Brazilian researchers are the only Latin American group to have had a project selected in an international request for applications by the Chan Zuckerberg Initiative. Funding of more USD 175,000 has been awarded to the study, which will be the first in Brazil to use single-cell analysis.


Researchers discover mechanism that makes COVID-19 more severe in diabetics
Researchers discover mechanism that makes COVID-19 more severe in diabetics

2020-06-03

Higher blood glucose levels captured by defense cells provide energy for augmented viral replication, triggering overwhelming immune response that kills lung cells.


FAPESP selects first projects in call to combat COVID-19
FAPESP selects first projects in call to combat COVID-19

2020-04-15

One of the studies will evaluate the effectiveness of drugs that inhibit bradykinin against pulmonary inflammation in critical patients. The other will analyze the transmission dynamics of the novel coronavirus in a small town in Amazonia.


Novel blood test points to risk of weight gain and diabetes
Novel blood test points to risk of weight gain and diabetes

2020-02-26

The blood test method makes use of machine learning and can be used to predict whether patients will put on weight, unless they change their habits. The project was conducted in Brazil with funding from FAPESP.


Zika inhibits the proliferation of prostate cancer cells
Zika inhibits the proliferation of prostate cancer cells

2020-01-23

Experiments performed by Brazilian scientists showed that Zika virus inhibits tumor cell proliferation even when inactivated by high temperature. The study was supported by FAPESP and published in Scientific Reports.